Pharma Marketing News Vol. 13, No. 6: June 2014
Welcome to Volume 13, Issue #6 (June 2014) of Pharma Marketing News.
Pharma DTC Advertising Spend vs. Time Consumers Spend in Various Media
I came upon an interesting chart in Mary Meeker’s state-of-the-Internet slide deck. Meeker — formerly of Morgan Stanley, at VC firm Kleiner Perkins since...
You say “Xareltor” and I say “Xalkori”: Whoops! There Goes Another Patient!
How should you name a new drug product? "That question," reports Alexander Gaffney (here), "is the subject of a new draft guidance by the...
Pharma: Your Brand Celebrity Spokespersons Are Worthless!
A survey developed by WP Engine and fielded by TNS found that nearly ALL consumers (96%) do NOT want to see stories about how...
Promotional Spending in 2013 of the Top 20 Big Pharma Spenders
I found an interesting table in the May 2014 issue of MM&M that presents promotional spending data for the top 20 -- based on...
Where’s the DTC Ads for Prophylactic Use of Truvada? Gilead, Support Your “Truvada Whores!”
As reported in the New York Times (see here) the Centers for Disease Control (CDC) recommended Wednesday that hundreds of thousands of Americans at...
Will FDA Avoid the “Social Media Guidance Cliff”?
Section 1121 of the Prescription Drug User Fee Act (PDUFA) states: "Not later than 2 years after the date of enactment , FDA shall...
Brand vs Corporate: A Distinction without a Difference in Social Media
"Do you want someone from corporate communications talking to your audience or should it be someone from the brand team who understands your audience...
When Big Pharma Sells Older Drugs, Is “Putting the Patient First” Devalued?
According to a Reuters article, "Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for...
The Emerging Virtual Medical Conference: Opportunities for Pharma, HCPs and Patients
'The medical conference is dead, long live the medical conference,' is the title of a SlideShare presentation by Len Starnes (@lenstarnes), a respected digital health-care consultant. Starnes is referring to the emergence of the 'virtual' medical conference, which he believes will soon be adopted in one form or another by all medical societies. This article describes the changes occurring viz-a-viz major medical conferences and the impact this will have on the pharmaceutical industry, medical societies, healthcare professionals, and patients.
